PSMB9 and dermatomyositis: A variety of studies have demonstrated that PSMB9 dysregulation contributes to autoimmune diseases, such as SS (53), rheumatoid arthritis (54), systemic lupus erythematosus (SLE) (51) and dermatomyositis (51).